Specifications include, but are not limited to: 1) The provider shall review the various aspects of the total drug dispensing system of HSH. These reviews will be designed to monitor and safeguard all areas of the drug dispensing system in order to assure safe and rational drug therapy to the patients and to determine the quality and storage of drugs used at HSH. 2) The provider shall make recommendations for upgrading patient care and improving the quality of life of HSH patients by providing quality clinical pharmacy services. The recommendations shall include drug product selection, formulary compliance, adjusting drug doses and schedules based on the monitoring of the effects of the drug therapies, and cost analysis and effectiveness of selected drug products. The recommendations shall be based upon medication reviews by the clinical pharmacist, who shall monitor for drug allergies, drug interactions, and contraindications for use, drug-food interactions, adverse drug reactions, dosing, polypharmacy, and other related data as required. 3) The provider shall provide comprehensive quality assurance programs to establish standards in order to assure optimal drug therapy and outcomes through the collection of medication usage data. The quality assurance programs shall be designed to assure that all drugs and biologicals used at the HSH are controlled, accountable and in compliance with all Federal and State laws.
